🇰🇷 Ultravist 370 in South Korea

Ultravist 370 (IOPROMIDE) regulatory status in South Korea.

Marketing authorisation

MFDS

  • Status: likely_approved

Ultravist 370 in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Other approved in South Korea

Frequently asked questions

Is Ultravist 370 approved in South Korea?

Yes. MFDS has authorised it.

Who is the marketing authorisation holder for Ultravist 370 in South Korea?

Bayer is the originator. The local marketing authorisation holder may differ — check the official source linked above.